Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01143532 · ClinicalTrials.gov registry record

Role of Donor Genetics and Recipient Genetics in Kidney Transplant Outcomes

A clinical trial, sponsored by National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK).

Completed
Registry status
26
Enrollment target

NCT01143532 is a clinical trial that has completed, run by National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK). The registered enrollment target is 26 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01143532 has completed, sponsored by National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK).

COMPLETED
Registry status
26 participants
Enrollment target

Study Summary

Background: \- Genetic variation in a particular chromosome is a major contributor to the increased risk for kidney disease that is common in people of African descent, although the specific gene, mutations, and other aspects of the variations remain to be determined. By studying the outcomes of kidney transplant in donors and recipients of African descent, researchers hope to better understand the effects of this genetic variation on the success of kidney transplants. Objectives: \- To examine possible connections between genetic variations and kidney transplant outcomes for donors and recipients. Eligibility: * Participants in kidney transplant where both donor and recipient were of black African descent. * Eligible transplants include both living donor and deceased donor. Design: * The study will involve one visit of up to 8 hours. * All participants will provide a detailed personal and family medical history. * All participants will provide blood and urine samples, including a 24-hour urine collection, to test kidney function and collect material for genetic testing. * Donor participants will also have a magnetic resonance imaging (MRI) scan of their remaining kidney.

Trial Details

FieldValue
Enrollment Target 26 participants
Start Date 2010-08-12
Est. Completion 2015-10-19

What the Registry Record Tells You About NCT01143532

The ClinicalTrials.gov registry entry for NCT01143532 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 26 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), which has 490 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 0 interventions.

NCT01143532 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT01143532 about?

NCT01143532 is a clinical study titled "Role of Donor Genetics and Recipient Genetics in Kidney Transplant Outcomes". Background: \- Genetic variation in a particular chromosome is a major contributor to the increased risk for kidney disease that is common in people of African descent, although the specific gene, mutations, and other aspects of the variations remain to be determined. By studying the outcomes of ki...

What is the current status of trial NCT01143532?

This trial is currently completed. The enrollment target is 26 participants. The study started on 2010-08-12. Estimated completion is 2015-10-19.

Who is sponsoring clinical trial NCT01143532?

This trial is sponsored by National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), which has 490 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.